Filters
COVID-19 infection does not appear to adversely affect ovarian reserve, and thus, the chance of success from assisted reproductive treatment likely remains the same as before infection, suggests a small study presented at ESHRE 2021.
Isolation during the COVID-19 pandemic may lead to deterioration in comorbidities and mental health, according to two studies presented at the European Society of Endocrinology virtual conference (e-ECE 2021).
Some COVID-19 patients experienced cognitive and behavioural problems within 2 months after discharge from hospital, with certain symptoms persisting to 10 months, reveals a longitudinal study presented at EAN 2021.
Patients with interstitial lung disease (ILD) are likely to develop physical frailty, which is independently associated with an increased risk of death, reports a study.
Exercise in patients with interstitial lung disease (ILD) may result in thoracoabdominal asynchrony (TAA) and higher recruitment of inspiratory accessory muscle, suggests a study.
Chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) are among respiratory conditions associated with an increased risk of severe COVID-19 outcomes, a recent study showed. However, the impact of respiratory disease on COVID-19 risk may not be as alarming as initially thought.
Improvements in overall survival (OS) and progression-free survival (PFS) were maintained with durvalumab in patients with unresectable stage III metastatic non-small cell lung cancer (NSCLC), according to updated results of the PACIFIC* trial presented at ASCO 2021.
Use of omalizumab for treating patients with severe allergic asthma in a real-world setting yields a steroid-sparing effect and helps minimize the occurrence of both clinically significant and severe asthma attacks, as reported in a study.
Patients with B-cell non-Hodgkin lymphoma hospitalized for COVID-19 are at an increased risk of developing persistent COVID-19 and death, according to a retrospective study presented at EHA 2021.
Patient-related factors, such as sex, comorbidities, and medical history, affect the risk of early mortality in drug-resistant tuberculosis (DR-TB), reports a recent meta-analysis.
